CAS: 1628317-18-9
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | MI-463 REF: AN-AG00AR6RCAS: 1628317-18-9 | 99% | A consultar | Mar 28 May 24 |
 | MI-463 REF: TM-TQ0058CAS: 1628317-18-9 | 100% | 59,00 €~500,00 € | Mar 04 Jun 24 |
 | MI-463 REF: 3D-DQC31718CAS: 1628317-18-9 | Min. 95% | A consultar | Mar 09 Jul 24 |
Ref: AN-AG00AR6R
| 5mg | 231,00 € | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 28 de Mayo de 2024
MI-463
CAS:1628317-18-9
MI-463 is a potent and orally bioavailable inhibitor of the menin-mLL interaction (IC50: 15.3 nM).
Fórmula:
C24H23F3N6S
Pureza:
100%
Forma y color:
Solid
Peso molecular:
484.54
Ref: TM-TQ0058
| 1mg | 59,00 € | |
| 5mg | 94,00 € | |
| 10mg | 149,00 € | |
| 25mg | 260,00 € | |
| 50mg | 371,00 € | |
| 100mg | 500,00 € | |
| 1ml*10 (DMSO) | 95,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Junio de 2024
MI-463
CAS:1628317-18-9
MI-463 is a drug that has been repurposed to treat cancer. It is a fatty …
Fórmula:
C24H23F3N6S
Pureza:
Min. 95%
Peso molecular:
484.54 g/mol
Ref: 3D-DQC31718
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 9 de Julio de 2024
